On June 3, 2026, Neurogene Inc. held its Annual Meeting with about 72.92% of shares represented. Key results include re-elections of directors Robert Baffi and Rohan Palekar, advisory approval of executive compensation, and ratification of Deloitte & Touche as the accounting firm for 2026.